Patient Support 24/7 : Assistance and answers whenever you need them
adults with overweight or obesity who initiated GLP-1 therapy between 2019 and 2024
transitory exanthema (widespread skin rash) Miscellaneous: Feeling of swelling of entire body Ingredients: Month 1 Homekit: Semaglutide/B12 0.25/0.125mg X 4 Injections Month 2 Homekit: Semaglutide/B12 0.5mg/0.25mg X 4 Injections Month 3 Homekit: Semaglutide/B12 1.0mg/0.125mg X 4 Injections Month 4 Homekit: Semaglutide/B12 1.7mg/0.25mg X 4 Injections, Semaglutide/B12 2.4mg X 1 Injections Month 5 Homekit: Maintenence Dosage (Month 5 and onward) Semaglutide/B12 2.5mg/0.25mg X 4 Injections REQUIREMENT: All our at-home kits include a physician assessment at no additional cost
Despite early signs of stabilization, long-term projections anticipate that, without major public health interventions, US adult obesity rates will remain high or resume increasing, potentially affecting over half of US adults by 20302050 [12, 13]
Owji AA, Khoshdel Z, Sanea F, Panjehshahin MR, Shojaee Fard M, Smith DM, et al
